RECIPIENTS DE THERAPIE SANGUINE COMPRENANT DES COMPOSITIONS DE POLYESTER FORMEES DE 2,2,4,4–TETRAMETHYL–1,3–CYCLOBUTANEDIOL AND 1,4–CYCLOHEXANEDIMETHANOL- Brevets EP1899400 (A1)

RECIPIENTS DE THERAPIE SANGUINE COMPRENANT DES COMPOSITIONS DE POLYESTER FORMEES DE 2,2,4,4–TETRAMETHYL–1,3–CYCLOBUTANEDIOL AND 1,4–CYCLOHEXANEDIMETHANOL

N° de brevet:	EP1899400 (A1)
Date de publication:	2008-03-19
Inventeur(s):	CRAWFORD EMMETT DUDLEY [US];PORTER DAVID SCOTT [US];CONNELL GARY WAYNE [US];
Demandeur(s):	EASTMAN CHEM CO [US];
Classification:	C08G63/199;C08L67/02;A61M1/00;A61M1/36;A61M1/02;
N° de demande:	EP20060740055 20060330
Numéro(s) de priorité:	WO2006US11662 20060330;US20050691567P 20050617;US20050731389P 20051028;US20050731454P 20051028;US20050738869P 20051122;US20050739058P 20051122;US20050750547P 20051215;US20050750682P 20051215;US20050750692P 20051215;US20050750693P 20051215

A lighting system operating using a digital mirror as its operative device. The digital mirror is used to shape the light which is passed through advanced optical devices to produce an output.